TWI298743B - Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same - Google Patents

Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same Download PDF

Info

Publication number
TWI298743B
TWI298743B TW094142275A TW94142275A TWI298743B TW I298743 B TWI298743 B TW I298743B TW 094142275 A TW094142275 A TW 094142275A TW 94142275 A TW94142275 A TW 94142275A TW I298743 B TWI298743 B TW I298743B
Authority
TW
Taiwan
Prior art keywords
acid
medium
fermentation
strain
kccm
Prior art date
Application number
TW094142275A
Other languages
Chinese (zh)
Other versions
TW200634150A (en
Inventor
Young Hoon Park
Hyoung Suk Kim
Jin Nam Lee
Ki Hoon Oh
Jeong Hwan Kim
Yoon Suk Oh
Jae Ick Sim
Kyung Oh Choi
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of TW200634150A publication Critical patent/TW200634150A/en
Application granted granted Critical
Publication of TWI298743B publication Critical patent/TWI298743B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/32Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15Corynebacterium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

1298743 v 九、發明說明: 【發明所屬之技術領域】 本發明關於一種可生產5、黃嘌呤酸之微生物以及使用 其之生產5 ’ -黃嘌呤酸的方法。特別地,本發明關於產廣 棒狀桿菌{Corynebacterium ammoniagenes) CJXFT0301 (1^(:€]\/1-105 3 0)之一種突變菌株產肩棒欢斧磨(:^又81110401 (KCCM-10609),其具有對磺胺二明:之抵抗性,導致二氫蝶 酸合成的增加以及最終導致四氫葉酸含量的上升,因此, φ 於相同的發酵期間,本發明之微生物能藉由直接發酵技術 生產較CJXFT0301 (KCCM-10530)菌株更高濃度以及更高 產量之5’-黃嘌呤酸。並且本發明也關於一種使用該突變 函株生產5 ’ -黃嗓吟酸之方法。 【先前技術】 5’-黃嘌呤酸,一核苷酸生物合成中之代謝中間產物, 於動物以及植物具有生理重要性,並且被廣泛使用於包含 食品以及製藥工業等領域以及用於種種醫療目的。特別 地’ 5’-黃吟酸係—在作為增進風味調味劑方面有吸引力 :核苦酸群組中的一種,因為當其結合麩胺酸鈉使用時能 高度增進食物的風味。 、 --山W 口;^、一 Τ间屋物, 並且在作為生產5,-电皇一 口人4十计私 馬翼&呤核苷酸之原料上為重要。 前,微生物發酵方法已被廣 連用於生產具有高調味活性 以及高商業價值之5,_烏一 性 ^異不7核苷酸。於微生物發酵中, 7 1298743 法Λ生產5’_黃°票呤酸’再將5,,呤酸進行 ’、 為_鳥糞嘌呤核苷酸。因此,基於對5,_島皇兩 呤核苦酸的需求,5,·黃。票吟酸須要被生產。 * —某:些方法係已知用於生產5,_黃嘌呤酸’該等方法包含 種藉由化子合成或降解酵母菌核糖核酸以生產5、島糞 嘌呤核苦酸之方法,並且該5,-鳥糞嗓呤核普酸被去胺基 化,並且包含-發酵方法,於該發酵方法中,係於發酵培 養基中補充黃呤嗓作為前驅物,利用微生物突變株,或^ •培養基中補充抗生素(日本專利案Sh〇 42_1477號以及心 44-20390號)或界面活性劑(日本專利案处〇 42_3825號以 及 Sho 42-3838 號)。 儿 如上所述,許多生產5,_黃嘌呤酸之方法已被知悉,而 經濟地生產咼浪度以及高產量的5,_黃嘌呤酸係最重要的 目標°於該f ^法巾’㈣微生物突變菌株直接發酵生產 5,-黃嗓呤酸係於工業上有利的。就這方面而言,發明人意 欲發展可顯著增進5,-鳥糞嘌呤核苷酸產量之微生物突變 • 菌株,其係藉由改良習知產廣#狀捧苈cjxFT0301 (KCCM_1〇53〇)的性質,賦予其生產最大量5,-鳥糞嗓呤核 苷酸之能力。因此,發明人發現一新穎之突變菌株,該突 變菌株係藉由將對磺胺二畊之抵抗性賦予習知的產歲襻欢 痒蔚CJXFT0301 (KCCM-l〇530)菌株而建立,並且該突變 菌株能於相同發酵期間藉由直接發酵生產高濃度以及高產 量之5 黃嘌呤酸,也因此導致本發明的產生。 8 1298743 【發明内容】 因此,本發明之一目的係提供一種微生物,其具有對 磺胺二畊之抵抗性並且能藉由直接發酵生產高濃度以及高 產量之5 ’ -黃嘌呤酸。 本發明之另一目的係提供一種藉由培養該微生物以生 產高濃度以及高產量之5、黃嘌呤酸之方法。 【實施方式】 本發明係關於產凌#狀#磨CJXSul0401 (KCCM-10609),其具有對磺胺二畊之抵抗性並且能生產高濃度以 及高產量之5’-黃嘌呤酸。 此外,本發明提供一種藉由培養產扇#狀#窗 CJXSul0401 (KCCM-10609)並且於培養液體中直接累積高 濃度以及高產量之5’-黃嘌呤酸以生產5’-黃嘌呤酸之方 法。 本發明中之微生物,產廣#狀#磨CJXSu10401 (KCCM-10609),係產扃 #狀# 磨 CJXFT0301 (KCCM-10530) 之一突變菌株。產肩/奏欢#磨CJXFT0301 (KCCM-10530) ’ 於本發明中被使用作為一親株(Parent strain),係被揭露於 韓國專利申請案第10-2003-089714號中。根據本發明之微 生物具有下列與產扃#狀#磨CJXFT0301 (KCCM-10530) 相同之主要特徵以及效力。 i) 對腺嘌呤之需求 ii) 對鳥糞嘌呤之需求 9 129.8743 iii) 對溶酶體之敏感性 iv) 對脯氨酸類似物之抵抗性 v) 對麩醯胺酸類似物之抵抗性 vi) 對色氨酸類似物之抵抗性 除了上述特性外,根據本發明之微生物產廣棒狀痒苈 CJXSuHMOl (KCCM-l〇6〇9)具有對磺胺二啡之抵抗性,並 且因此能於培養液體中直接累積較高濃度以及較高產量之 5、黃嗓呤酸。 5、黃嗓呤酸(XMP)之生物合成路徑係非常複雜的,並 且係一系列之反應,多種胺基酸以及輔酶皆牵涉其中。特 別地’ XMP生物合成路徑自磷酸核糖焦磷酸(PRPP)至XMP 係由11個反應逐步完成。並且,2個分子的麩醯胺酸、1 個分子的甘氨酸、1個分子的天門冬胺酸、丨個分子的hc〇3· 以及2個分子的ΝΑ,亞曱基四氫葉酸(THF_ch〇)被包含 於该等反應中。因此,增加加入這些被包含於嘌呤鹼基形 成之原料可幫助嘌呤鹼基之合成。 石頁胺二啡係一磺胺類抗生素,其係對氨基苯甲酸(paba) 之一結構衍生物。磺胺二畊能阻斷二氫蝶酸合成酶之作 用,並且因此阻止葉酸合成中間物,二氫蝶酸,之產生。 由於此作用’〜胺二啡能抑制微生物内四氫葉酸之合成。 四氣葉酸於嗓吟、胸腺嘧啶、DNA以及類似分子之合 成,演著關鍵性的角色。㈣,四氫葉酸含量之下降會抑 制U生物之生長。具有磺胺二畊抵抗性之菌株,cjxSu1〇4〇1 (KCCM-1 0609) ’係意欲增加二氫蝶酸之合成以克服磺胺二 1298743 啡所弓—I起之生長抑制。此因而增加了黃嗓吟酸合成所必須 之四氫葉酸的總量。此四氫葉酸含量的增加導致黃嘌呤酸 被大量合成,相較於習知技術,由此可造成藉由直接發酵 法產生高濃度以及高產量之5,·黃嗓吟酸。而此發現導致 本發明的產生。 微生物可藉由X射線、紫外光、化學誘變劑(例如, 曱基硝基亞硝基鳥糞嘌呤、硫酸二乙酯、乙胺等)以 及頒似物而穴變。為獲得根據本發明之微生物,立廣#欢 • #磨CJXF丁0301 (KCCM-1〇53〇)被使用作為親株。為獲得 能存活於磺胺二畊存在下之突變無性繁殖系,該親株係根 據.亥員技藝中常使用之方法,以一誘變劑,甲基專确基 γΝ-亞硝基鳥糞嘌呤(NTG)處理,並且於補充有各種濃度之 ’、月女一啡的培養基中篩選,該等培養基被標記為“Μ] ”,其 於表2中被描述。本發明之微生物被篩選自經由上述方法 所獲得之突變無性繁殖系。 磺胺二畊係包含於使用於本發明測試之培養基中,其 瞻含里為5 mg/L。親株產扃捧欢捧磨CJXF丁〇3〇1對磺胺二 啡之抵抗性可達〇」mg/L,並且其無法生長於含有〇 2mg/L 或更高濃度之磺胺二畊中。相反地,被選擇之對磺胺二畊 具有抵抗性之菌株,產廣#狀#磨CJXSiil0401 (KCCM- 1〇6〇9),被發現可生長於甚至i mg/Li磺胺二啡中。1298743 v IX. Description of the Invention: [Technical Field of the Invention] The present invention relates to a microorganism capable of producing 5, xanthanic acid and a method for producing 5'-xanthene using the same. In particular, the present invention relates to a mutant strain of Corynebacterium ammoniagenes CJXFT0301 (1^(:€]\/1-105 3 0), which produces a shoulder-stick axe mill (:^ and 81110401 (KCCM-10609) ), which has resistance to sulfamethoxazole, leads to an increase in the synthesis of dihydropteryric acid and ultimately to an increase in the content of tetrahydrofolate, and therefore, the microorganism of the present invention can be directly fermented during the same fermentation period. A higher concentration and higher yield of 5'-xanthic acid than the CJXFT0301 (KCCM-10530) strain is produced. And the present invention also relates to a method for producing 5'-xanthic acid using the mutant protein. 5'-xanthic acid, a metabolic intermediate in the synthesis of nucleotides, is of physiological importance in animals and plants, and is widely used in the fields of food and pharmaceutical industries, and for various medical purposes. 5'-xanthic acid system - attractive as a flavor-enhancing flavoring agent: one of the group of nucleotides, because it can highly enhance the flavor of food when it is combined with sodium glutamate. - Mountain W mouth; ^, a room between the house, and in the production of 5, - electric emperor a person of the 40th private horse wing & 呤 呤 nucleotides of the raw material is important. Before, the microbial fermentation method has been Guanglian is used to produce 5 nucleotides with high flavoring activity and high commercial value. In microbial fermentation, 7 1298743 Λ produces 5'_黄°票呤酸' and then 5, , tannic acid carries ', is _ bird feces 嘌呤 nucleotides. Therefore, based on the demand for 5, _ island 呤 呤 呤 苦, 5, · yellow. Ticket citrate needs to be produced. * - Some: some methods It is known to be used for the production of 5,-xanthine'. These methods include a method of synthesizing or degrading yeast ribonucleic acid by a chemical to produce 5, island faecal acid, and the 5,-guano The guanidine acid is deaminated and comprises a fermentation method in which the scutellaria is supplemented in the fermentation medium as a precursor, using a mutant strain of the microorganism, or supplementing the antibiotic in the medium (Japanese patent) Case Sh〇42_1477 and Heart 44-20390) or surfactant (Japanese Patent Office) No. 42_3825 and Sho No. 42-3838. As mentioned above, many methods for producing 5,_xanthic acid have been known, and the economical production of 咼 wave and high yield of 5,_xanthic acid is the most important. The target is directly industrially fermented by the direct fermentation of the microbial mutant strain of the f ^ method (4). The xanthate is industrially advantageous. In this respect, the inventors intend to develop a significant increase in the 5,-guano sputum nucleus. Microbial mutations in the production of glycosidic acid • The strain, which is capable of producing the maximum amount of 5,-guanine nucleotides, by improving the properties of the well-known cultivar cjxFT0301 (KCCM_1〇53〇). Therefore, the inventors have found a novel mutant strain which is established by imparting resistance to sulfonamide to the conventional strain of CJXFT0301 (KCCM-l〇530), and the mutation is established. The strain is capable of producing high concentration and high yield of 5 xanthic acid by direct fermentation during the same fermentation, which also leads to the production of the present invention. 8 1298743 SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide a microorganism having resistance to sulfonamide and capable of producing high concentration and high yield of 5'-xanthic acid by direct fermentation. Another object of the present invention is to provide a method for producing a high concentration and a high yield of 5, xanthanic acid by culturing the microorganism. [Embodiment] The present invention relates to a CJXSul0401 (KCCM-10609) which has resistance to sulfonamide and can produce a high concentration and a high yield of 5'-xanthene. Further, the present invention provides a method for producing 5'-xanthic acid by culturing a fan-shaped window CJXSul0401 (KCCM-10609) and directly accumulating a high concentration and a high yield of 5'-xanthic acid in a culture liquid. . The microorganism of the present invention is produced by a CJXSu10401 (KCCM-10609), which is a mutant strain of CJXFT0301 (KCCM-10530). The shoulder/playing #磨CJXFT0301 (KCCM-10530)' is used as a parent strain in the present invention, and is disclosed in Korean Patent Application No. 10-2003-089714. The microorganism according to the present invention has the following main features and potency similar to those of the calcareous CJXFT0301 (KCCM-10530). i) demand for adenine ii) demand for guano sputum 9 129.8743 iii) sensitivity to lysosomes iv) resistance to proline analogues v) resistance to glutamate analogues vi Resistance to tryptophan analogs In addition to the above-described characteristics, the microbial sputum CJXSuHMO1 (KCCM-l〇6〇9) produced by the microorganism according to the present invention has resistance to sulfamethine and is therefore capable of being cultured. A higher concentration and a higher yield of 5, xanthanic acid are directly accumulated in the liquid. 5. The biosynthetic pathway of xanthine (XMP) is very complex and is a series of reactions involving a variety of amino acids and coenzymes. In particular, the XMP biosynthetic pathway from the phosphoribosyl pyrophosphate (PRPP) to the XMP system was gradually completed by 11 reactions. Furthermore, two molecules of glutamic acid, one molecule of glycine, one molecule of aspartic acid, one molecule of hc〇3· and two molecules of hydrazine, fluorenyltetrahydrofolate (THF_ch〇) ) is included in the reactions. Therefore, the addition of these starting materials which are included in the base of the purine can help the synthesis of purine bases. A sulphate di- sulfonamide antibiotic which is a structural derivative of p-aminobenzoic acid (paba). Sulfonamide dimerization blocks the action of dihydropteroate synthetase and thus prevents the formation of folate synthesis intermediate, dihydropteroic acid. Because of this effect, ~amine dimorphine can inhibit the synthesis of tetrahydrofolate in microorganisms. Four-gas folate plays a key role in the synthesis of sputum, thymine, DNA and similar molecules. (d) The decrease in the content of tetrahydrofolate inhibits the growth of U organisms. A strain having sulfonamide resistance, cjxSu1〇4〇1 (KCCM-1 0609)' is intended to increase the synthesis of dihydropteric acid to overcome the growth inhibition of sulfamethoxazole 1298743. This thus increases the total amount of tetrahydrofolate necessary for the synthesis of ruthenic acid. This increase in the content of tetrahydrofolate causes a large amount of synthesis of samaric acid, which results in a high concentration and a high yield of lycopene by a direct fermentation method as compared with the prior art. This finding has led to the production of the present invention. The microorganisms can be acupointed by X-rays, ultraviolet light, chemical mutagens (e.g., mercaptonitronitroguanine, diethyl sulfate, ethylamine, etc.) and the like. In order to obtain the microorganism according to the present invention, Li Guang #欢•#磨CJXF丁0301 (KCCM-1〇53〇) was used as a parent strain. In order to obtain a mutant vegetative propagation line which can survive in the presence of sulfonamide, the parent strain is a mutagen, methyl-specific γΝ-nitrosoguanamine 根据 according to the method commonly used in the art of Haier. NTG) was treated and screened in media supplemented with various concentrations of 'moon-female-one, which were labeled "Μ", which is described in Table 2. The microorganism of the present invention is screened from the mutant vegetative propagation line obtained by the above method. Sulfonamide was included in the medium used for the test of the present invention, and it was 5 mg/L. The pro-chicken 扃 扃 欢 捧 C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C Conversely, the strain selected to be resistant to sulfonamide was found to be CJXSiil0401 (KCCM-1〇6〇9) and was found to grow in even i mg/Lisulfonamide.

該被選擇之突變無性繁殖系被定名為“產肩#说#磨 CJXSU1G401,其於2004年n月16日依據布達佩斯條約 被寄存於韓國微生物培養中心(K〇rean Cuhure W 11 1298743The selected mutant asexual reproduction line was named "Maternal shoulder #说#磨CJXSU1G401, which was deposited at the Korea Microbiology Center (K〇rean Cuhure W 11 1298743) on July 16, 2004 under the Budapest Treaty.

Microorganisms, KCCM ; Hongjae 1-dong ^ Seodaemun-gu ^ Seoul,Republic of the K0rea),並且被給予登錄號(Accessi〇n number)KCCM-10609。產扇捧欢择磨 CJXSul〇4〇1 亦已寄 存於食品工業發展研究所,寄存編號為Bcrc 910307。 於本發明中所分離之新穎突變菌株CjxSu1〇4〇i (KCCM-1 0609),具有如表一所描述之生化性質,且係能夠 生長於補充以1 mg/L磺胺二畊的培養基中。 本發明中之突變菌株具有如表一所描述對磺胺二啡有 | 抵抗性之性質,於表一中,係針對該突變菌株與親株 CJXFT〇3〇l對磺胺二畊之抵抗性作比較。 表一 磺胺二味 卜濃度 (mg/L) 0 0.1 0.2 0.3 0.5 1 2 5 CJXFT0301 + + + ++ — 一 一 CJXSu0401 (KCCM-1 0609) + + + + + + + + + + + + +厂 + — — 附註:+ :生長;—:無生長; 該等菌株被培養於30°C,5天。 使用本發明之新穎菌株生產5,_黃嘌呤酸之方法如下。 根據本發明之產廣#欢#磨CJXSiil0401 (KCCM_10609) 菌株被培養於含有適當碳源、氮源、胺基酸以及維生素之 慣用培養基中,於有氧狀態下,並且如溫度以及pH值等 因子皆受到控制。 可利用之碳源的實例包含碳水化合物如葡萄糖、果糖 以及無菌處理後之糖蜜(即,被轉化為還原糖之糖蜜)。適 合之氮源的實例包含無機氮源,如尿素、氯化銨以及硫酸 銨,以及有機氮源,如蛋白腺(Peptone)、NZ_胺、肉萃取 12 129.8743 物(Meat extract)、酵母菌萃取物、玉米浸潰液(c〇ni steep liquor)、赂蛋白水解物(casein hydrolysate)、魚類或其分 解產物,以及除去脂肪之大豆餅或其分解產物。 可利用之無機化合物的實例包含填酸一卸、碟酸二鉀、 硫酸鎮、硫酸亞鐵、硫酸錳以及碳酸鈣。根據所需意圖, 培養基可進一步補充以維生素、外營性鹼基(Auxotrophic base)以及類似物。 培養係於好氧環境(Aer〇bic c〇n(jition)下進行,舉例而 _ 言’伴隨著搖動或通氣-攪動,於較佳地20至40°C。於培 養期間’培養基係較佳地保持於接近中性pH。培養持續5 至6天。5’-黃嘌呤酸,藉由直接發酵而累積,係根據慣用 的方法進行分析。 、、口果,§使用遠親株CJXFT0301藉由直接發酵生產5,· =嗓呤酸時,152·2 g/L之5,_黃嘌呤酸被獲得。相對地, 田使用本^明之犬變菌株,羞羲捧欢岸磨c以Sui〇4〇1時, 160.4 g/L之5’_黃嘌呤酸於相同環境下被獲得。此等結果 鲁指出,相較於親株CJXFT〇3〇1,CJXSul〇4〇l株,獲得對磺 胺二畊之抵抗性,具有增進的5,_黃嘌呤酸產量。 々—關於本發明之進一纟了解可藉由以T實施例獲得,該 等實施例提出以闡述而非限制本發明。 實施例 立於本發明中之微生物培養係使用描述於如下之表2中 I 土而進仃,包含營養培養基(定名為“ΜΓ)、基本培 土 (疋名為“M2”)、含有磺胺二畊之培養基(定名為 13 1298743 )用於燒瓶中之種子培養(Seed culture)的培養基(定 ‘名為“M4”)、帛於燒瓶中之主要發酵的培養基(定名為 M5 )、用燒瓶發酵(Flask fermentati〇n)之隔離滅菌培養基 (定名為“M6”)、用於發酵槽中之第…種子培養的培養基(定 名為“M7”)、用於發酵槽中之第二_種子培養的培養基(定名 為“M8”)以及用於發酵槽中主要發酵之培養基(定名為 M9”)。然而’培養基並不受限於列在表2中的成份,並 且所有適合培養產桌#狀捍磨之培養基皆係可利用的。Microorganisms, KCCM; Hongjae 1-dong ^ Seodaemun-gu ^ Seoul, Republic of the K0rea), and was given accession number (Accessi〇n number) KCCM-10609. CJXSul〇4〇1 has also been deposited with the Food Industry Development Institute under the registration number Bcrc 910307. The novel mutant strain CjxSu1〇4〇i (KCCM-1 0609) isolated in the present invention has the biochemical properties as described in Table 1, and is capable of growing in a medium supplemented with 1 mg/L sulfonamide. The mutant strain of the present invention has the property of resistance to sulfamethine as described in Table 1, and in Table 1, the resistance of the mutant strain to the parent strain CJXFT〇3〇l to sulfonamide was compared. Table I Sulfonamide Digestion Concentration (mg/L) 0 0.1 0.2 0.3 0.5 1 2 5 CJXFT0301 + + + ++ — One CJXSu0401 (KCCM-1 0609) + + + + + + + + + + + + + + — — Note: + : growth; —: no growth; the strains were cultured at 30 ° C for 5 days. The method for producing 5,-xanthic acid using the novel strain of the present invention is as follows. The strain CJXSiil0401 (KCCM_10609) according to the present invention is cultured in a conventional medium containing a suitable carbon source, a nitrogen source, an amino acid, and a vitamin, under aerobic conditions, and factors such as temperature and pH. All are under control. Examples of carbon sources that may be utilized include carbohydrates such as glucose, fructose, and aseptically processed molasses (i.e., molasses that is converted to reducing sugar). Examples of suitable nitrogen sources include inorganic nitrogen sources such as urea, ammonium chloride, and ammonium sulfate, and organic nitrogen sources such as Peptone, NZ-amine, meat extraction 12 129.8743 (Meat extract), yeast extraction , c〇ni steep liquor, casein hydrolysate, fish or its decomposition products, and fat-free soy cake or its decomposition products. Examples of inorganic compounds that may be utilized include acid-removal, dipotassium silicate, sulphuric acid, ferrous sulfate, manganese sulfate, and calcium carbonate. The medium may be further supplemented with vitamins, Auxotrophic bases, and the like, depending on the intended purpose. The culture is carried out in an aerobic environment (Aer〇bic c〇n (jition), for example, with shaking or aeration-stirring, preferably at 20 to 40 ° C. During the culture, the medium is preferably The soil is kept close to neutral pH. The culture lasts for 5 to 6 days. 5'-xanthic acid, accumulated by direct fermentation, is analyzed according to the conventional method. 、, 果果, § using the distant relative strain CJXFT0301 by direct When fermenting 5,· = tannic acid, 52.2 g/L of 5,5 g/L was obtained. In contrast, the field used the dog strain of this Ming, shy, holding Huai C to Sui〇4 At 1 o'clock, 160.4 g/L of 5'_xanthic acid was obtained under the same environment. These results indicate that compared with the parental strain CJXFT〇3〇1, CJXSul〇4〇1 strain, obtained the sulfonamide two tillage Resilience, with enhanced 5,_xanthene production. 々 - Further understanding of the present invention can be obtained by the use of the T embodiment, which is set forth to illustrate and not to limit the invention. The microorganism culture system of the present invention comprises a nutrient medium using the soil described in Table 2 below. A medium named "ΜΓ", a basic culture (named "M2"), a medium containing sulfonamide (named 13 1298743) for seed culture in a flask (defined as 'M4') ), the main fermentation medium in the flask (named M5), the flask sterilization (Flask fermentati〇n) isolation sterilization medium (named "M6"), the medium used for the seed culture in the fermentation tank (named "M7"), the medium used for the second seed culture in the fermentation tank (named "M8") and the medium used for the main fermentation in the fermentation tank (named M9). However, the medium is not It is limited to the ingredients listed in Table 2, and all media suitable for the culture table are available.

表二Table II

培養基 成份 Ml 巧g/L葡!糖、1〇 g/L蛋白脒、1〇 g/JL酵母菌萃取物、 2· g/L氣化納、3 g/L尿素、150 mg/L腺嘌呤、150 mg/L鳥糞嘌呤,pH為7.2 & M2 20 g/L之葡刼糖、1 g/L之碟酸一卸、1 g/L之碌酸二卸、 2 g/L之尿素、3 g/L之硫酸銨、1 g/L之硫酸鎂、1〇〇 mg/L 之氯化鈣、20 mg/L之硫酸亞鐵、1〇 mg/L之硫酸錳、1〇 mg/L 之硫酸鋅、30 pg/L之生物素(Biotin)、0.1 mg/L之噻胺 HC1、0·8 mg/L 之硫酸銅、20 mg/L· 之腺嘌呤、20 mg/L· 之鳥糞嘌呤,pH為7.2 M3 培養基藉由加入0.1、0.2、0.3、0.5、1、2以及5 mg/L 之磺胺二啡至最低營養素培養基中(M2)而製備 M4 3 0 g/L之葡萄糖、15 g/L之蛋白腺、15 g/L之酵母菌萃 取物、2.5 g/L之氯化納、3 g/L之尿素、150 mg/L之腺 嘌呤、150 mg/L之鳥糞嘌呤,PH為7.2 M5 60 g/L之葡萄糖、10 g/L之硫酸鎂、20 mg/L之硫酸亞鐵、 10 mg/L之硫酸鋅、1〇 mg/L之硫酸錳、30 mg/L之腺嗓 呤、30 mg/L之鳥糞嘌呤、1〇〇 pg/L之生物素、1 mg/L i 硫酸銅、5 mg/L之噻胺HC1、10 mg/L之氣化鈣,pH為 7.2 ”、 M6 1 0 g/L之填酸一鉀、1 〇 g/L之填酸二卸、7 g/L之尿素、 5 g/L之硫酸銨 μ M7 3 0 g/L之葡萄糖、15 g/L之蛋白腺、15 g/L之酵母菌萃 取物、2.5 g/L之氯化鈉、3 g/L之尿素、150 mg/L之腺 屬呤、150 mg/L之鳥糞嘌呤,pH為7.2 1 M8 瞧 ----- 60 g/L之葡萄糖、2 g/L之磷酸一鉀、2 g/L之磷酸二钾、 :· g/L之硫酸鎂、22 mg/L之硫酸亞鐵、1 5 mg/L之硫酸鋅、 10 mg/L之硫酸錳、1 mg/L之硫酸鋼、100 mg/L之氣化 耗、150 ug/L之生物素、150 mg/L之腺嘌呤、150 mff/T 14 129.8743 g/L之葡萄糖、32 g/L之磷酸、25 g/L之氫氧化鉀 M9 石六腺气:令、119 mg/L之鳥糞嗓呤、60 mg/L之 瓜夂亞鐵、42 mg/L之硫酸鋅、1 5 mg/L之硫酸锰、2.4 mg/L 之硫酉夂銅、22 mg/L之丙胺酸、7.5 mg/L之NCA、0.4 mg/L 之生物素、15 g/L之硫酸鎂、3〇mg/L之半胱氨酸、30mg/L 之組胺酸、149 mg/L之氣化鈣、15 mg/L之噻胺HC1、0.7 5劑、27 ml/L之玉米浸潰液(CSL)、6 g/L之 鮪魚卒取物,pH為7.3 實施例1 :抗磺胺二啡菌株之建立 根據本發明之突變菌株被如下建立。產廣捧狀斧磨 參CJXFT0301 (KCCM-10530)被使用作為親株並且以最終濃 度為30 pg/ml2 N-甲基_N_硝基亞硝基鳥糞嘌呤處理, 於30。(:進行60分鐘以誘發突變。接著,該親株被以〇·85% 之生理食鹽水洗滌三次,並且適當地以一培養基稀釋,該 培養基係藉由加入1 mg/L之磺胺二明:至一包含17%之瓊 月曰糖的基本培養基(M2)而製備,並且接著將該稀釋後之親 株塗抹於一固體培養基上。每個出現的菌落皆被培養於營 養培養基(Ml)、種子培養基(M4)中24小時,並且接著被 • 培養於發酵培養基(M5)以及隔離滅菌培養基(M6)之混合培 養液中4天。於該等無性繁殖系中,能生產最高產量之5,_ 黃嘌呤酸,其係累積於培養液體中,的無性繁殖系被選擇。 該被選擇之無性繁殖系被定名為“產扃捧说痒磨 CJXSU10401”,其於2〇〇4年n月16曰依據布達佩斯條約 被寄存於韓國微生物培養中心,並且被給予登錄號KCCm 10609 。 ' 實施例2 ·於歐蘭麥氏(Erlenmeyer)燒瓶中之發酵 15 129.8743 (Titer test)檢測 使用之菌株:CJXSul0401以及CJXFT0301 用於燒瓶中之種子培養的培養基:列於表二之M4 用於燒瓶中之主要發酵的培養基:列於表二之 用於燒瓶發酵之隔離滅菌培養基:列於表二之M6 5 ml之種子培養培養基被等份分裝至直徑為i8㈤瓜之 ”式吕中,並且根據習知方法於高壓下滅菌。每一菌株皆被 接種於無菌種子培養中,並且於3 〇。〇培育18小時,伴隨 著180 rpm之搖動。此種子培養物被使用作為發酵之接種 原(Inoculum)。用於主要發酵之培養基以及隔離滅菌培養 基被單獨地根據習知方法於高壓下滅菌,並且分別以29 ml 以及10 ml被等份分裝至500-ml之搖動歐蘭麥氏燒瓶。丨ml 之種子培養物被接種於該等燒瓶中,並且培育90小時。 養被只行於30°C,伴隨著200 rpm之搖動。之後,於培 液體中’被生產以及累積於培養液體之5,_黃嘌呤酸的 里被測定。藉由習知菌株CJXFT0301 (KCCM-10530)所生 產之5’_黃噪呤酸被發現以28 6 g/L之濃度累積於培養液 ’而本發明之突變菌株CJXSul0401 (KCCM-10609)所 生產之黃嘌呤酸則以30_7 g/L之濃度累積於培養液體 中。5 -黃嗓呤酸(χΜΡ)之累積濃度係由5,-ΧΜρ · Na3 · 7h2〇 給定。 實施例3 :於發酵槽中之發酵力價檢測 使用之菌株:CJXSul0401以及CJXFT0301 用於發酵槽中之第一-種子培養的培養基··列於表二之M7 1295743Medium composition Ml 巧g/L Portuguese! Sugar, 1〇g/L peptone, 1〇g/JL yeast extract, 2·g/L gasification sodium, 3 g/L urea, 150 mg/L adenine 150 mg/L guano cockroach, pH 7.2 & M2 20 g/L glucosinolate, 1 g/L disc acid unloading, 1 g/L bismuth acid unloading, 2 g/L urea , 3 g / L of ammonium sulfate, 1 g / L of magnesium sulfate, 1 〇〇 mg / L of calcium chloride, 20 mg / L of ferrous sulfate, 1 〇 mg / L of manganese sulfate, 1 〇 mg / L-zinc sulfate, 30 pg/L biotin (Biotin), 0.1 mg/L thiamine HC1, 0.8 mg/L copper sulfate, 20 mg/L·adenine, 20 mg/L· Avian guanidine, pH 7.2 M3 medium Prepared M4 3 0 g/L glucose by adding 0.1, 0.2, 0.3, 0.5, 1, 2 and 5 mg/L sulfamethoxazole to the lowest nutrient medium (M2) 15 g/L protein gland, 15 g/L yeast extract, 2.5 g/L sodium chloride, 3 g/L urea, 150 mg/L adenine, 150 mg/L guano嘌呤, pH is 7.2 M5 60 g/L glucose, 10 g/L magnesium sulfate, 20 mg/L ferrous sulfate, 10 mg/L zinc sulfate, 1 mg/L manganese sulfate, 30 mg/ L adenine, 30 Mg/L guano, 1〇〇pg/L biotin, 1 mg/L i copper sulfate, 5 mg/L thiamine HC1, 10 mg/L calcium carbonate, pH 7.2”, M6 10 g/L of potassium monobasic acid, 1 〇g/L of acid-filled acid, 7 g/L of urea, 5 g/L of ammonium sulfate μ M7 3 0 g/L of glucose, 15 g/L Protein gland, 15 g/L yeast extract, 2.5 g/L sodium chloride, 3 g/L urea, 150 mg/L gland guanidine, 150 mg/L guanine, pH 7.2 1 M8 瞧----- 60 g/L glucose, 2 g/L monopotassium phosphate, 2 g/L dipotassium phosphate, :· g/L magnesium sulfate, 22 mg/L sulfuric acid Iron, 15 mg/L zinc sulfate, 10 mg/L manganese sulfate, 1 mg/L sulfuric acid steel, 100 mg/L gasification consumption, 150 ug/L biotin, 150 mg/L gland嘌呤, 150 mff/T 14 129.8743 g/L glucose, 32 g/L phosphoric acid, 25 g/L potassium hydroxide M9 stone six gland gas: 119 mg/L guano, 60 mg/ L guar ferrous iron, 42 mg/L zinc sulphate, 15 mg/L manganese sulphate, 2.4 mg/L sulphur bismuth copper, 22 mg/L alanine, 7.5 mg/L NCA, 0.4 Mg/L biotin, 15 g/L magnesium sulfate, 3 〇mg/L cysteine Acid, 30mg/L histidine, 149 mg/L calcium carbonate, 15 mg/L thiazide HC1, 0.7 5 dose, 27 ml/L corn steep liquor (CSL), 6 g/L Salmon feed, pH 7.3 Example 1: Establishment of a sulfonamide-resistant strain The mutant strain according to the present invention was established as follows. The abundance of the axe was used. The CJXFT0301 (KCCM-10530) was used as a parent strain and treated with a final concentration of 30 pg/ml2 N-methyl_N_nitronitrosoguanine, at 30. (: The mutation was induced for 60 minutes. Then, the parent strain was washed three times with 85% physiological saline, and appropriately diluted with a medium by adding 1 mg/L of sulfamethoxazole: Prepared by a basic medium (M2) containing 17% of Qiongyue sugar, and then the diluted parent strain is spread on a solid medium. Each of the emerging colonies is cultured in a nutrient medium (Ml), seed medium. (M4) for 24 hours, and then cultured in a mixed culture medium of fermentation medium (M5) and isolated sterilization medium (M6) for 4 days. In these asexual reproduction lines, the highest yield can be produced 5,_ Astragalus acid, which is accumulated in the culture liquid, is selected as the vegetative propagation line. The selected asexual reproduction line is named as "Yuyu holding itch mill CJXSU10401", which is in 2 years and 4 years. 16曰 was deposited in the Korean Microbiology Center according to the Budapest Treaty and was given accession number KCCm 10609. 'Example 2 · Fermentation in Erlenmeyer flask 15 129.8743 (Titer test) Test used strain: C JXSul0401 and CJXFT0301 medium for seed culture in flasks: M4 listed in Table 2 Medium for main fermentation in flasks: Isolation and sterilizing medium for flask fermentation listed in Table 2: M6 5 listed in Table 2 The seed culture medium of ml is aliquoted into the formula of i8 (five) melon and sterilized under high pressure according to the conventional method. Each strain is inoculated in sterile seed culture and cultured at 3 〇. 18 hours, with shaking at 180 rpm. This seed culture was used as a fermentation inoculum (Inoculum). The medium for the main fermentation and the isolated sterilization medium were separately sterilized under high pressure according to a conventional method, and respectively 29 ml and 10 ml were aliquoted into 500-ml shaken oulander flasks. Seed cultures of 丨ml were inoculated into the flasks and incubated for 90 hours. The rearing was only performed at 30 °C. It was shaken with 200 rpm. After that, it was measured in the liquid of the culture medium and accumulated in the culture liquid, 5,_xanthic acid. It was produced by the conventional strain CJXFT0301 (KCCM-10530). 5'_yellow citric acid was found to accumulate in the culture solution at a concentration of 28 6 g/L' while the scutellaria acid produced by the mutant strain CJXSul0401 (KCCM-10609) of the present invention accumulated at a concentration of 30-7 g/L. In the culture liquid, the cumulative concentration of 5-xanthic acid (χΜΡ) is given by 5,-ΧΜρ · Na3 · 7h2〇. Example 3: Fermentation force in the fermentation tank: the strain used: CJXSul0401 and CJXFT0301 Medium for the first-seed culture in the fermentation tank·· listed in Table 2, M7 1295743

二-種子培養的培養基··列於表二之M8 要發酵的培養基:列於表二之M9 用於發酵槽中之第 用於發酵槽中之主 第_種子培養:50 ml之第一 _種子培養基被等份分裝 至5 00 ml之搖動區人蘭麥氏燒瓶,在高壓下於im減菌μ min jl且冷部。各個菌株被接種至該等無菌培養基中, 亚且於3〇°C培育24小時,伴隨著18〇rpm之搖動。 第二-種子培養:2公升之第二_種子培養基被等份分裝 至5公升之實驗發酵槽中,在高壓下於i2i〇(:滅菌2〇min,Two-seed culture medium ··M8 listed in Table II Fermentation medium: M9 listed in Table 2 The main _ seed culture used in the fermentation tank for the fermentation tank: 50 ml first _ The seed culture medium was aliquoted into a 500 ml shaken zone Renlan's flask, and under the high pressure, the microorganism was reduced by μ min jl and cold. Each strain was inoculated into the sterile medium and incubated at 3 °C for 24 hours with shaking at 18 rpm. Second-seed culture: 2 liters of the second _ seed medium was aliquoted into 5 liters of experimental fermentation tank, under high pressure at i2i (: 2 〇 min,

並且v卻5 〇 mi之則述第一-種子培養物被接種至該發酵 槽中並且於31 C培育24小日夺,伴隨著900 rpm之搖動 乂及0_5 vvm之通氧。培養基於發酵期間被以氨水(八叫⑶旧 ammonia)調整至 pH 7.3。 發酵:8公升之用於主要發酵的培養基被等份分裝至3〇 公升之實驗發酵槽中,在高壓下於121〇c滅菌2〇 min,並 且冷卻。1.5 L之第二-種子培養物被接種至該發酵槽中, 並且於33°C培育,伴隨著400 rpm之攪拌以及1 vvm之通 氣。於發酵期間,當殘餘糖的量低於1 %時,無菌之葡萄 糖被補充至培養基中以調節該培養基中用於主要發酵之整 體的糖量至30%。培養基於發酵期間被以氨氣(Amm〇niagas) 調整至pH 7.3。整個發酵被實施80小時。之後,被生產 以及累積於培養基中之5、黃嘌呤酸的量被測定。藉由習 知菌株CJXFT0301 (KCCM-10530)所生產之5,-黃嘌呤酸被 發現以152.2 g/L之濃度累積於培養液體中,而本發明之 突變菌株CJXSul0401 (KCCM-10609)所生產之5,-黃嘌呤酸 17 I2R8743 ♦暫 則以160.4 g/L之濃度累積於培養液體中。5、黃嘌呤酸(XMP) 之累積濃度係由5’-XMP · Na3 · 7H20給定。 工業應用性 如前文所描述,根據本發明之產廣#狀#磨 CJXSuHMOl (KCCM-10609)菌株能經濟地藉由直接發酵生 產比習知菌株更高濃度以及更高產量之5 黃嘌呤酸。 【圖式簡單說明】 無 【主要元件符號說明】 無And v but 5 〇 mi said that the first-seed culture was inoculated into the fermentation tank and incubated at 31 C for 24 days, with shaking at 900 rpm and oxygen at 0-5 vvm. The culture was adjusted to pH 7.3 with ammonia water (eight (3) old ammonia) during the fermentation. Fermentation: 8 liters of the medium for the main fermentation was aliquoted into 3 liters of the experimental fermentation tank, sterilized at 121 °c for 2 Torr at high pressure, and cooled. 1.5 L of the second-seed culture was inoculated into the fermentation tank and incubated at 33 ° C with stirring at 400 rpm and 1 vvm of vent gas. During the fermentation, when the amount of residual sugar is less than 1%, sterile glucose is added to the medium to adjust the amount of sugar in the medium for the main fermentation to 30%. The culture was adjusted to pH 7.3 with ammonia (Amm〇niagas) based on the fermentation period. The entire fermentation was carried out for 80 hours. Thereafter, the amount of 5, xanthanic acid produced and accumulated in the medium was measured. 5,-xanthic acid produced by the conventional strain CJXFT0301 (KCCM-10530) was found to accumulate in the culture liquid at a concentration of 152.2 g/L, and the mutant strain CJXSul0401 (KCCM-10609) of the present invention was produced. 5,-xanthic acid 17 I2R8743 ♦ temporarily accumulated in the culture liquid at a concentration of 160.4 g / L. 5. The cumulative concentration of xanthine (XMP) is given by 5'-XMP · Na3 · 7H20. Industrial Applicability As described above, the strain CJXSuHMO1 (KCCM-10609) according to the present invention can economically produce higher concentrations and higher yields of 5 xanthic acid than conventional strains by direct fermentation. [Simple diagram description] None [Main component symbol description] None

1818

Claims (1)

申請專利範圍 f7年/修正本 1· 一種寄存於食品工業發办 研九所寄存編號為BCRC 910307 的微生物產扇/凑说γ,广 i < 悍狀才干菌(c〇rynebacteri_ ammoniagenes ) CJXSul0401,該微生物具有對磺胺二啡 之抵抗性並且能生產5’-黃嘌呤酸。 2· —種生產5’-黃嘌呤酸之方法,該方法係基於培養 根據申請專利範圍第1項所述之微生物,以於培養液體中 生產5 ’ -黃嗓呤酸。Patent application scope f7 years/amendment 1 1. A microbial production fan/coin γ, i 才 才 〇 寄存 寄存 寄存 寄存 寄存 寄存 寄存 , , , , , , , , 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物 微生物The microorganism has resistance to sulfamethine and is capable of producing 5'-xanthic acid. A method for producing 5'-xanthic acid based on cultivating a microorganism according to the first aspect of the patent application to produce 5'-xanthic acid in a culture liquid. 十一、圖式:XI. Schema:
TW094142275A 2004-12-01 2005-12-01 Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same TWI298743B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040100026A KR100588578B1 (en) 2004-12-01 2004-12-01 Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same

Publications (2)

Publication Number Publication Date
TW200634150A TW200634150A (en) 2006-10-01
TWI298743B true TWI298743B (en) 2008-07-11

Family

ID=36565291

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094142275A TWI298743B (en) 2004-12-01 2005-12-01 Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same

Country Status (3)

Country Link
KR (1) KR100588578B1 (en)
TW (1) TWI298743B (en)
WO (1) WO2006059877A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101072720B1 (en) * 2008-12-17 2011-10-11 씨제이제일제당 (주) A corynebacteria having enhanced 5'-guanosine monophosphate productivity and a method of producing 5'-guanosine monophosphate using the same
KR102013873B1 (en) 2018-01-25 2019-08-23 씨제이제일제당 주식회사 A microorganism of the genus Corynebacterium producing purine nucleotide and method for producing purine nucleotide using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0716431B2 (en) * 1986-06-02 1995-03-01 協和醗酵工業株式会社 Process for producing 5'-guanylic acid
JP3016883B2 (en) * 1991-02-19 2000-03-06 協和醗酵工業株式会社 Method for producing 5'-xanthylic acid by fermentation method
JP2000295996A (en) * 1999-02-08 2000-10-24 Kyowa Hakko Kogyo Co Ltd Production of purine nucleotide
KR100344016B1 (en) * 2000-04-08 2002-07-20 제일제당주식회사 5'-Xanthylic acid producing microorganism
KR100429925B1 (en) * 2001-12-28 2004-05-03 씨제이 주식회사 Microorganism overproducing 5’-xanthylic acid
KR100505925B1 (en) * 2002-12-11 2005-08-03 씨제이 주식회사 Microorganism producing 5’-Xanthylic acid

Also Published As

Publication number Publication date
KR20060061135A (en) 2006-06-07
WO2006059877A1 (en) 2006-06-08
TW200634150A (en) 2006-10-01
KR100588578B1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
JP4864138B2 (en) Method for producing L-arginine using Corynebacterium glutamicum
JPH03232497A (en) Production of l-glutamine by fermentation
EP1346026B1 (en) Microorganism producing 5'-inosinic acid and process for producing 5'-inosinic acid using the same
KR20070056491A (en) Microorganisms having a gene purf and production method of xanthosine 5'-monophosphate using the same
TWI298743B (en) Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same
KR100542568B1 (en) A Microorganism producing 5'-Xanthylic acid
JP2004180672A (en) Microorganism which produces riboflavin and method for producing the riboflavin by using the same
KR100959662B1 (en) Inosine producing microorganism belonging to the genus Corynebacterium and process of producing inosine using the same
US7078222B2 (en) Microorganism for producing riboflavin and method for producing riboflavin using the same
KR20020057470A (en) A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same
RU2312140C2 (en) Strain corynebacterium ammoniagenes as producer of 5'-xanthylic acid and method for preparing 5'-xanthylic acid
JP4035135B2 (en) Microorganism producing 5'-xanthylic acid
KR100694427B1 (en) Microorganisms of corynebacterium and processes of preparing 5'-inosinic acid using same
KR100402322B1 (en) A microorganism Corynebacterium ammoniagenes CJXP002 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same
CN102586383A (en) Process for preparing cytidine diphosphate choline
KR100671081B1 (en) Microorganism producing inosine and process of preparing 5'-inosinic acid using same
KR970007200B1 (en) Preparation of erythritol
KR100454888B1 (en) Microorganism producing 5'-inosinic acid
KR830001259B1 (en) Method for producing L-glutamine by microorganisms
KR890000537B1 (en) Process for preparing 5'guanylic acid through fermentation
KR100671080B1 (en) Microorganism producing inosine and process of preparing 5'-inosinic acid using same
KR970002252B1 (en) MICROORGANISM PRODUCING 5óÑ-XANTHYL ACID
KR860000248B1 (en) Method for producing 5'xantil acid by microorganism
KR920005976B1 (en) Method for preparation of l-glutamire
KR20090076614A (en) Inosine producing microorganism belonging to the genus corynebacterium and process of producing inosine using the same